The prices of traditional Chinese medicine have skyrocketed, and many pharmaceutical listed companies have “self built planting bases” that are not afraid of fluctuations

On May 16th, the Kangmei China Traditional Chinese Medicine Price Index was at 1987.3 points, while the previous day, the index was at 1988.14 points, setting its highest historical value since its release in 2013. Previously, CCTV Finance reported that the Chinese herbal medicine market experienced a bull market in the first quarter, with downstream pharmaceutical companies experiencing a sharp increase in procurement costs, and some Chinese herbal medicines experiencing “three prices per day”. According to multiple Chinese medicine pharmaceutical listed companies, respondents all stated that the price increase of Chinese medicine is mainly due to weather factors, coupled with the recovery of downstream consumer demand, and the market has a certain degree of sustainability. If there are self built planting bases and regular inventory, it is expected to smoothly overcome the bull market situation of Chinese medicine.